DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Immunohistochemical assay are 9




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0004Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
Brazilian strain ZKV2015
NA
Immunohistochemical assay
Decrease (10 %)
Approved
29150641
DrugRepV_0027Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Zika virus
GZ01, a recent Asian lineage
NA
Immunohistochemical assay
Decrease (85 %)
Approved
29033372
DrugRepV_0291Kaletra
Antiinfectives For Systemic Use
Acquired immunodeficiency syndrome
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Immunohistochemical assay
Decrease (>90 %)
Approved, Investigational
26198719
DrugRepV_0293Betaferon
Antineoplastic and Immunomodulating Agents
Multiple sclerosis
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Immunohistochemical assay
Decrease (>90 %)
Approved
26198719
DrugRepV_0295Mycophenolate Mofetil
Immunosuppressant
Organ rejection (immunosuppressants)
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Immunohistochemical assay
No significant effect
Approved, Investigational
26198719
DrugRepV_0752Favipiravir
Antiviral
Influenza virus
Nipah virus
NiV-Malaysia
NA
Immunohistochemical assay
Decrease
Investigational
29765101
DrugRepV_0755Favipiravir
Antiviral
Influenza virus
Nipah virus
NiV-Malaysia
NA
Immunohistochemical assay
Decrease
Investigational
29765101
DrugRepV_3863Favipiravir
Antiviral
Influenza virus
Lassa virus
Josiah
NA
Immunohistochemical assay
Decrease (50 %)
Investigational
27736754
DrugRepV_5675Bortezomib
Antineoplastic and Immunomodulating Agents
Multiple Myeloma
Dengue virus
EDEN 3295
Pathway
Immunohistochemical assay
Decrease (50 %)
Approved
26565697